首页> 外文期刊>Iranian Journal of Medical Sciences >High Flow Nasal Cannulae versus Nasal Continuous Positive Airway Pressure in Neonates with Respiratory Distress Syndrome Managed with INSURE Method: A Randomized Clinical Trial
【24h】

High Flow Nasal Cannulae versus Nasal Continuous Positive Airway Pressure in Neonates with Respiratory Distress Syndrome Managed with INSURE Method: A Randomized Clinical Trial

机译:INSURE方法管理的新生儿呼吸窘迫综合征高流量鼻导管与鼻腔持续气道正压通气:一项随机临床试验

获取原文
           

摘要

Background: In recent years, various noninvasive respiratory support (NRS) of ventilation has been provided more in neonates. The aim of this study was to compare the effect of HFNC with NCPAP in post-extubation of preterm infants with RDS after INSURE method (intubation, surfactant, extubation). Methods: A total of 54 preterm infants with RDS (respiratory distress syndrome) were enrolled in this study. Using a randomized sequence, they were assigned into two groups after INSURE method. The first group received HFNC while the second group received NCPAP for respiratory support after extubation. A comparison was made between these two groups by the rate of reintubation, air leak syndrome, duration of oxygen therapy, hospitalization, the rate of bronchopulmonary dysplasia (BPD), intraventricular hemorrhage (IVH), retinopathy of prematurity (ROP), and mortality. Data were analyzed by using the SPSS version 18 software. The statistical analyses included Student’s t-test for continuous data and compared proportions using Chi-squared test and Fisher‘s exact test for categorical data. Result: The rate of reintubation was higher in the HFNC compared with the NCPAP group. The rate of either IVH or ROP had no significant differences between the two groups. In addition, duration of oxygen requirement and hospitalization were not statistically different. There was no case of BPD or mortality among these patients. Conclusion: This study showed that preterm infants with RDS could manage post-extubation after INSURE method with either NCPAP or HFNC. However, in this single-center study, the rate of reintubation was higher in the HFNC group while further multicenter study might be assigned. Trial Registration Number: IRCT201201228800N1
机译:背景:近年来,新生儿中提供了更多的各种无创通气支持(NRS)。这项研究的目的是比较INSURE方法(插管,表面活性剂,拔管)后,HFNC和NCPAP在RDS早产儿拔管后的效果。方法:本研究共纳入54例RDS(呼吸窘迫综合征)早产儿。使用随机序列,在INSURE方法后将它们分为两组。第一组在拔管后接受HFNC,第二组接受NCPAP进行呼吸支持。通过再插管的发生率,漏气综合征,氧气治疗的持续时间,住院,支气管肺发育不良(BPD),脑室内出血(IVH),早产儿视网膜病变(ROP)和死亡率进行了比较。使用SPSS 18版软件分析数据。统计分析包括对连续数据的学生t检验,并使用卡方检验和Fisher精确检验对类别数据进行比例比较。结果:与NCPAP组相比,HFNC的再插管率更高。两组的IVH或ROP发生率无显着差异。此外,需氧量和住院时间无统计学差异。这些患者中没有BPD或死亡的病例。结论:这项研究表明,使用NCPAP或HFNC进行INSURE方法后,RDS早产儿可以进行拔管后治疗。但是,在该单中心研究中,HFNC组的再插管率更高,而可能会分配更多的多中心研究。试用注册号:IRCT201201228800N1

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号